From the point of view of DNA repair by homologous recombination triple-negative breast cancers were characterized by preponderance of BRCA1 mutations whereas hereditary non-triple-negative breast cancers by preponderance of CHEK2 mutations over mutations in other genes involved in this type of DNA repair tested in our report. The gene discussed is BRCA1; the disease is triple-negative breast carcinoma.